Prognostic value of breast cancer aromatase

Allan Lipton, Richard J. Santen, Steven J. Santner, Harold A. Harvey, Sherry I. Sanders, Yvonne Matthews

Cancer · 1992 · 79 citations · 20 references

Concepts

Abstract

The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease-free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease-free interval or survival.

References

20